Advertisement

Topics

Adult and Pediatric Hemoconcentrators Market to Surpass US$ 14.3 Million by 2026 – Coherent Market Insights

08:30 EST 14 Feb 2019 | Businesswire

Coherent Market Insights

According to Coherent Market Insights, the adult and pediatric hemoconcentrators market was valued at US$ 10.7 million in 2017, and is projected to exhibit a CAGR of 3.3% over the forecast period (2018–2026).

Key Trends and Analysis of the Adult and Pediatric Hemoconcentrators Market:

A hemoconcentrator is a device used for removal of excess fluid during cardio bypass surgery. High prevalence of cardiovascular diseases around the globe is expected to be a major factor for high demand for hemoconcentrators in the market and drive global adult and pediatric hemoconcentrators market growth. For instance, according to the data published by World Health Organization (WHO) in 2017, cardiovascular disease is the leading cause of deaths, globally. Annually, more people die from cardiovascular disease than from any other cause in the world.

Ask for a Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/2483

According to the data published by American Heart Association in 2018, around 92.1 million adults in the U.S. are suffering from some form of cardiovascular disease or the after-effects of stroke. Cardiovascular disease, listed as the underlying cause of death, annually accounts for around 836,546 deaths in the U.S.

Major players in the market are involved in strategic mergers and partnership activities, in order to expand its product portfolio, presence, and increase share in global adult and pediatric hemoconcentrators market.

For instance, in 2015, Italy-based Sorin S.p.A, a manufacturer of hemoconcentrators with presence in France, Italy, Japan, and Texas, merged with Cyberonics, Inc., a U.S.-based company. The newly formed company was named LivaNova, Plc. With this, the merged company is expected to strengthen and expand its presence in the global market.

In 2016, MEDIVATORS Inc. (a Cantel Medical Corporation company), a manufacturer of Hemocor HPH family hemoconcentrators, expanded its direct sales operations in Canada by acquiring endoscope reprocessing business assets from its Canadian distributor, Vantage Endoscopy, Inc., a subsidiary of Diploma Canada Holdings Ltd.

However, stringent rules by regulating bodies such as product recalls by U.S. Food and Drug Administration (FDA) might hamper adult and pediatric hemoconcentrators market growth. For instance, in 2015, U.S. Food and Drug Administration recalled Terumo Custom Cardiovascular Procedure Kit X-Coated Adult Pak. The custom cardiovascular procedure kits contain recalled component Medivators HPH700, the high performance hemoconcentrators.

To know the latest trends and insights prevalent in this market, click the link below:

https://www.coherentmarketinsights.com/market-insight/adult-and-pediatric-hemoconcentrators-market-2483

Key Market Takeaways:

  • The market is expected to exhibit a CAGR of 3.3% over forecast period (2018–2026). This growth is attributed to high prevalence of cardiovascular disease in key regions such as North America and Asia Pacific.
  • North America adult and pediatric hemoconcentrators market is expected to account for the largest market share during the forecast period, owing to high prevalence of cardiovascular disease in the U.S. For instance, according to the data published by the National Center for Biotechnology Information in 2016, in the U.S., over 350,000 suffered from out-of-hospital cardiac arrest (OHCA) and about 209,000 people suffered from in-hospital cardiac arrest (IHCA), with a survival rate of 12% and 24.9%, respectively.
  • China and India are expected to exhibit high growth in Asia Pacific adult and pediatric hemoconcentrators market, due to rising geriatric population that is more prone to cardiovascular diseases
  • Major key players are involved in strategic merger and acquisition activities for the development and distribution of novel adult and pediatric hemoconcentrators and to expand their presence
  • Some of the major players operating in the global adult and pediatric hemoconcentrators market include Medivators Inc., Terumo Corporation, LivaNova, PLC, Maquet (a Getinge Group company), Medica S.p.A, and others.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Mr. Shah
Coherent Market Insights
1001 4th Ave.
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

NEXT ARTICLE

More From BioPortfolio on "Adult and Pediatric Hemoconcentrators Market to Surpass US$ 14.3 Million by 2026 – Coherent Market Insights"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pediatrics
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...

Cardiology
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...

Surgical treatments
Surgery is a technology consisting of a physical intervention on tissues. All forms of surgery are considered invasive procedures; so-called "noninvasive surgery" usually refers to an excision that does not penetrate the structure being exci...